mapping the effectiveness and risks of glp-1 receptor agonists pdf agonism: a transformative approach for managing type-2 diabetes obesity | Saudi Pharmaceutical Journal Mapping the effectiveness and risks

Schoretsanitis, G., Weiler, S., Barbui, C., Raschi, E

Chen, Q

The Allurion Balloon helps you feel fuller on smaller portions and fuller for longer so you are likely to eat less, while the comprehensive 6-18 month behavioural change programme helps you readjust your mindset towards food and adopt healthier habits check your eligibility here

PB: Writing review & editing

In a 12-month, two-phase trial, subcutaneously administered lixisenatide moderately reduced the progression of motor dysfunction in patients with early Parkinsons disease (PD) compared to placebo (Meissner et al., 2024)

Animals with biopsy-confirmed steatosis and fibrosis received ALT-801, semaglutide, elafibranor, or vehicle daily for 12 weeks while maintained on the AMLN diet